Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bronchiolitis: update 2001.

Cory Schlesinger1, Michael N Koss

  • 1Bostwick Laboratories, Richmond, Virginia 23294, USA. cschlesinger@bostwicklaboratories.com

Current Opinion in Pulmonary Medicine
|February 15, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of Cyclin D1 as a Discriminatory Immunohistochemical Biomarker for Idiopathic Pulmonary Fibrosis.

Applied immunohistochemistry & molecular morphology : AIMM·2018
Same author

Claudin-18-mediated YAP activity regulates lung stem and progenitor cell homeostasis and tumorigenesis.

The Journal of clinical investigation·2018
Same author

Further Studies of Unsuspected Emphysema in Nonsmoking Patients With Asthma With Persistent Expiratory Airflow Obstruction.

Chest·2017
Same author

Handling and interpretation of the medical renal biopsy.

Methods in molecular biology (Clifton, N.J.)·2014
Same author

A middle-aged man with cough, chest pain, and pulmonary artery filling defect: primary pulmonary artery sarcoma.

Chest·2014
Same author

Pulmonary nodular lymphoid hyperplasia (pulmonary pseudolymphoma): the significance of increased numbers of IgG4-positive plasma cells.

The American journal of surgical pathology·2013
Same journal

Toward precision imaging in interstitial lung disease: advances in quantitative imaging and artificial intelligence.

Current opinion in pulmonary medicine·2026
Same journal

Oxygen therapy in interstitial lung disease - navigating benefit and burden.

Current opinion in pulmonary medicine·2026
Same journal

Preclinical and clinical advances in pulmonary hypertension associated with systemic sclerosis.

Current opinion in pulmonary medicine·2026
Same journal

Advancing lung transplantation: current challenges and future directions.

Current opinion in pulmonary medicine·2026
Same journal

Association between upper airway obstruction and pulmonary hypertension in children with Down syndrome.

Current opinion in pulmonary medicine·2026
Same journal

Molecular mechanisms of environmental risk factors for interstitial lung disease.

Current opinion in pulmonary medicine·2026
See all related articles

This review summarizes recent findings on infant bronchiolitis and respiratory syncytial virus (RSV). It covers viral mechanisms, mortality, biomarkers, genetic susceptibility, and treatments like Palivizumab and ribavirin.

Area of Science:

  • Pediatric Pulmonology
  • Infectious Diseases
  • Epidemiology

Background:

  • Bronchiolitis is a common infant respiratory illness, often associated with Respiratory Syncytial Virus (RSV).
  • Understanding viral mechanisms and risk factors is crucial for effective management and prevention.
  • Recent research explores novel biomarkers and therapeutic strategies.

Purpose of the Study:

  • To review and synthesize the latest research on infant bronchiolitis and RSV-associated illnesses.
  • To highlight advancements in understanding disease mechanisms, epidemiology, and treatment options.
  • To consolidate information on emerging conditions like eosinophilic bronchiolitis and BOOP.

Main Methods:

  • Literature review of reports published in the last year.

Related Experiment Videos

  • Synthesis of findings from epidemiological studies, clinical trials, and case reports.
  • Evaluation of diagnostic markers and prophylactic/therapeutic interventions.

    • Main Results:

    • RSV remains a primary cause of infant bronchiolitis, with ongoing research into its impact on airway function and mortality.
    • Serum eosinophilic cationic protein shows potential as a marker for persistent wheezing.
    • Parental bronchial responsiveness may indicate genetic susceptibility.
    • Palivizumab demonstrated efficacy in controlling RSV outbreaks, while ribavirin's role in acutely ill children was evaluated.
    • New associations with bronchiolitis obliterans organizing pneumonia (BOOP) were reported, with methotrexate considered an alternative to corticosteroids.
    • Eosinophilic bronchiolitis emerged as a newly described entity.

    Conclusions:

    • Recent research provides valuable insights into the multifaceted aspects of infant bronchiolitis and RSV.
    • Continued investigation into biomarkers, genetic factors, and novel treatments is warranted.
    • The review highlights the evolving understanding of related respiratory conditions and their management.